Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · IEX Real-Time Price · USD
7.00
+0.01 (0.14%)
At close: Jul 19, 2024, 4:30 PM
6.99
-0.01 (-0.14%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Coya Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Coya Therapeutics stock have an average target of 16, with a low estimate of 14 and a high estimate of 18. The average target predicts an increase of 128.57% from the current stock price of 7.00.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 13, 2024.
Analyst Ratings
The average analyst rating for COYA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +157.14% | Jun 13, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +100.00% | Jun 5, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +100.00% | May 9, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +100.00% | Apr 29, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $14 | Strong Buy | Maintains | $11 → $14 | +100.00% | Mar 20, 2024 |
Financial Forecast
Revenue This Year
5.20M
from 6.00M
Decreased by -13.33%
Revenue Next Year
6.89M
from 5.20M
Increased by 32.35%
EPS This Year
-1.20
from -0.79
EPS Next Year
-1.57
from -1.20
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 8.9M | 10.5M | 31.5M |
| Avg | 5.2M | 6.9M | 30.6M |
| Low | 1.7M | 3.4M | 29.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 48.7% | 101.8% | 357.5% |
| Avg | -13.3% | 32.4% | 344.4% |
| Low | -72.2% | -34.1% | 327.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.17 | -1.37 | -0.46 |
| Avg | -1.20 | -1.57 | -0.45 |
| Low | -1.23 | -1.73 | -0.43 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.